The 2021 Global Lung Cancer Therapy Landscape. Deb D, et al.J Thorac Oncol. 2022 Jul;17(7):931-936.PMID:35489693. Abs of…

この記事を読む
一臨床医の勉強のための備忘録です。間違いなどあればご指摘を頂ければ幸いです。
この記事を読む
The 2021 Global Lung Cancer Therapy Landscape. Deb D, et al.J Thorac Oncol. 2022 Jul;17(7):931-936.PMID:35489693. Abs of…
この記事を読む
Patterns of Failure and Optimal Treatment Paradigm for Large, Inoperable, Node-Negative Non-small Cell Lung Cancer. Schn…
この記事を読む
High dose osimertinib in patients with advanced stage EGFR exon 20 mutation-positive NSCLC: Results from the phase 2 mul…
この記事を読む
A prognostic score for patients with malignant pleural mesothelioma (MPM) receiving second-line immunotherapy or chemoth…
この記事を読む
Bevacizumab Plus Atezolizumab After Progression on Atezolizumab Monotherapy in Pretreated Patients With NSCLC: An Open-L…
この記事を読む
Tumour cell budding and spread through air spaces in squamous cell carcinoma of the lung – Determination and valid…
この記事を読む
Rebiopsy in advanced non-small cell lung cancer, clinical relevance and prognostic implications. Scheffler M et al.Lung …
この記事を読む
Impact of Tumor Suppressor Gene Co-Mutations on Differential Response to EGFR TKI Therapy in EGFR L858R and Exon 19 Dele…
この記事を読む
EGFR mutation is not a prognostic factor for CNS metastasis in curatively resected lung adenocarcinoma patients. Liu X e…
この記事を読む
Investigation on the survival implications of PD-L1 expression status in ALK- rearranged advanced non-small cell lung ca…